← Clinical Evidence

SRC-3cc9d68842c3 Lipsmeier F 2022

Evidence source and scope

Lipsmeier F, Taylor KI, Postuma RB, et al. Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson's Disease. Scientific Reports. 2022. DOI 10.1038/s41598-022-15874-4

This note indexes a cited or audit-added source. It may be an original study, review, guideline, form or methods reference. Treat the specific design and the evidence below as authoritative; a source note is not automatically a primary study.

DOI: 10.1038/s41598-022-15874-4

Bibliographic record from the original reports

Access labels embedded in these original reference strings are historical. Current access and exact checked components are stated separately below.

Lipsmeier F, Taylor KI, Postuma RB, et al. Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson's Disease. Scientific Reports. 2022. DOI 10.1038/s41598-022-15874-4

Conditions: COND-PD Parkinson’s disease

Scoped audit evidence

These are source- and component-level audit summaries as of 3 October 2026. Access and comparison scope can differ by report; none certifies every result or the underlying raw data.

Parkinson’s disease — balance

Balance P319/P395–397: selected early drug-naive PD; front-waist belt30s,arms at sides;median of>=3 observations per two-week period. Table1 balance ICC.82(.76–.87),postural item correlation.14;H&Y1vs2 p=.387. No single-trial ICC or MIC/control norms established. Source locator: s3 Table1;s15 population;s16 protocol;s18 quality control;s19 aggregation/statistics Limit: Evidence cannot transfer to a one-off home score.

Limitations: Only scoped comparisons, not whole-paper certification.

Parkinson’s disease — balance1

Balance P319/P395–397: selected early drug-naive PD; front-waist belt30s,arms at sides;median of>=3 observations per two-week period. Table1 balance ICC.82(.76–.87),postural item correlation.14;H&Y1vs2 p=.387. No single-trial ICC or MIC/control norms established. Source locator: s3 Table1;s15 population;s16 protocol;s18 quality control;s19 aggregation/statistics Limit: Evidence cannot transfer to a one-off home score.

Limitations: Only scoped comparisons, not whole-paper certification.

Reports citing this source

Update record

Updating the wiki · Evidence and status guide